Discover a breakthrough drug in the treatment of osteoporosis with Teriparatide from Demei Pharmaceutical Technology Co., Ltd. Teriparatide, also known as human parathyroid hormone (PTH), is a medication used to treat osteoporosis by increasing new bone formation. It is the only FDA-approved anabolic (bone-building) medication available for the treatment of osteoporosis, Teriparatide works by stimulating osteoblasts, the cells responsible for bone formation, leading to an increase in bone mineral density. This medication has been shown to reduce the risk of fractures in postmenopausal women with osteoporosis and in men with primary or hypogonadal osteoporosis, Demei Pharmaceutical Technology Co., Ltd. is dedicated to providing high-quality pharmaceutical products for the treatment of various diseases, including osteoporosis. With Teriparatide, patients can now have access to an effective and innovative treatment option for increasing bone strength and reducing the risk of fractures. Trust Demei Pharmaceutical Technology Co., Ltd. to deliver the best in osteoporosis treatment with Teriparatide
Please feel free to give your inquiry in the form below We will reply you in 24 hours